Global Prothrombin Complex Concentrates Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Prothrombin Complex Concentrates Market Insights, Forecast to 2034
Prepared from large pools of normal donor plasma, the prothrombin complex concentrates contain the vitamin K–dependent clotting factors prothrombin, FVII, FIX, and FX, as well as anticoagulant proteins C and S.
Global Prothrombin Complex Concentrates market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Prothrombin Complex Concentrates industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Prothrombin Complex Concentrates key manufacturers include Takeda, Octapharma AG, CSL Behring GmbH and Grifols, etc. Takeda, Octapharma AG, CSL Behring GmbH are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Prothrombin Complex Concentrates were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Prothrombin Complex Concentrates market and estimated to attract more attentions from industry insiders and investors.
Prothrombin Complex Concentrates can be divided into 3F Prothrombin Complex Concentrates and 4F Prothrombin Complex Concentrates, etc. 3F Prothrombin Complex Concentrates is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Prothrombin Complex Concentrates is widely used in various fields, such as Compound Pharmacies, Hospital Pharmacies and Retail Pharmacies,, etc. Compound Pharmacies provides greatest supports to the Prothrombin Complex Concentrates industry development. In 2022, global % sales of Prothrombin Complex Concentrates went into Compound Pharmacies filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Prothrombin Complex Concentrates market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Prothrombin Complex Concentrates market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Takeda
Octapharma AG
CSL Behring GmbH
Grifols
Segment by Type
3F Prothrombin Complex Concentrates
4F Prothrombin Complex Concentrates
Compound Pharmacies
Hospital Pharmacies
Retail Pharmacies
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Prothrombin Complex Concentrates plant distribution, commercial date of Prothrombin Complex Concentrates, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Prothrombin Complex Concentrates introduction, etc. Prothrombin Complex Concentrates Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Prothrombin Complex Concentrates
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Prothrombin Complex Concentrates market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Prothrombin Complex Concentrates industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Prothrombin Complex Concentrates key manufacturers include Takeda, Octapharma AG, CSL Behring GmbH and Grifols, etc. Takeda, Octapharma AG, CSL Behring GmbH are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Prothrombin Complex Concentrates were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Prothrombin Complex Concentrates market and estimated to attract more attentions from industry insiders and investors.
Prothrombin Complex Concentrates can be divided into 3F Prothrombin Complex Concentrates and 4F Prothrombin Complex Concentrates, etc. 3F Prothrombin Complex Concentrates is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Prothrombin Complex Concentrates is widely used in various fields, such as Compound Pharmacies, Hospital Pharmacies and Retail Pharmacies,, etc. Compound Pharmacies provides greatest supports to the Prothrombin Complex Concentrates industry development. In 2022, global % sales of Prothrombin Complex Concentrates went into Compound Pharmacies filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Prothrombin Complex Concentrates market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Prothrombin Complex Concentrates market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Takeda
Octapharma AG
CSL Behring GmbH
Grifols
Segment by Type
3F Prothrombin Complex Concentrates
4F Prothrombin Complex Concentrates
Segment by Application
Compound Pharmacies
Hospital Pharmacies
Retail Pharmacies
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Prothrombin Complex Concentrates plant distribution, commercial date of Prothrombin Complex Concentrates, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Prothrombin Complex Concentrates introduction, etc. Prothrombin Complex Concentrates Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Prothrombin Complex Concentrates
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports